Management of aggressive malignancies, such as glioma, is complicated by a lack of predictive biomarkers that could reliably stratify patients based on treatment outcome. The complex mechanisms driving glioma recurrence and treatment resistance cannot be fully understood without the integration of multiscale factors such as cellular morphology, tissue microenvironment, and macroscopic features of the tumor and the host tissue. We present a weakly-supervised, interpretable, multimodal deep learning-based model fusing histology, radiology, and genomics features for glioma survival predictions. The proposed framework demonstrates the feasibility of multimodal integration for improved survival prediction in glioma patients.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.